NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink
HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65 | Retrovirology | Full Text
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation | Science
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines | Journal of Neuroinflammation | Full Text